Navigation Links
ULURU Inc. Announces Odd-Lot Buy Back Offer
Date:10/30/2007

urgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Hydrogel Nanoparticle Aggregate technology. For further information about ULURU Inc., please visit our website at http://www.uluruinc.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including but not limited to statements made relating to the value of our products in the marketplaces, our ability to develop and market our technologies, commercialization of products in the marketplace and to the future financial performance of ULURU Inc. (the "Company"). These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2006 and other reports filed by us with the Securities and Exchange Commission.

Contact: Company

Kerry P. Gray

President & CEO

Terry K. Wallberg

Vice President & CFO

(214) 905-5145


'/>"/>
SOURCE ULURU Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)... Fans Can ,Start Their Engines, and Nominate Now a...TSBURGH, July 9 /PRNewswire/ -- TUMS, one of the m...elief, is launching a nationwide search for,one lu...QuikPak 500 Sprint,Cup Series race at Martinsville...., (Photo: http://www.newscom.com/cgi-bin/prnh/2...
(Date:7/9/2008)...o be heavier if they spend a lot of time on the In...uly 9 (HealthDay News) -- Teen girls who spend a ... their weight creeping slowly up than adolescents ...n, new research shows. , And the association be...the researchers accounted for the amount of exerci...
(Date:7/9/2008)... global needs for the increasingly complex healthc... YORK, July 9 /PRNewswire/ -- Cohn & Wolfe has ann...ealthcare public relations firm,specializing in a... which,will be led by Jill Dosik as president, off... marketing strategy and leading-edge digital healt...
(Date:7/9/2008)...and, July 9 /Xinhua-PRNewswire/ -- Chindex,Interna...ican provider of,international healthcare services...epublic of China, today announced that its Healthc...ncommercial China travel health,information websit...p://www.ChinaHealthWatch.org ) is a,comprehensive...
Breaking Medicine News(10 mins):Health News:TUMS Announces Nationwide Search for Grand Marshal at TUMS QuikPak 500 2Health News:Surfing to a Higher Weight 2Health News:Surfing to a Higher Weight 3Health News:Cohn & Wolfe Launches GCI Health, One of the World's Largest Healthcare Public Relations Firms 2Health News:Chindex's United Family Healthcare Launches ChinaHealthWatch.org - A global resource for travelers to China 2
...w technique for checking the spread of cancer of t...se. Cancer of the oesophagus - the tube leading fr... a year in the UK, making it the eighth most commo...r through the lymph glands. But it is hard for doc...
...ntists warn that, too much sleep and snoring could...researchers from the University of Buffalo, New Yo... a night, snoring or being drowsy during the day c...s means snoring and sleep disorders will now have ...
...new genes which are active in prostate cancer have... level, cancer tissue differs markedly from normal...esearchers have now developed the tools that can v...hat characterise the cancerous cell. Using microar...
...ican doctors are using a computer to do a double c...gular mammogram tests to check for early breast ca.... Researchers at the Sloan-Kettering Cancer Resear... detection (CAD) to help analyse lesions that a fi...
Other Medicine News:
(Date:7/9/2008)... Research Has Set National Safety Standards, B...wire-USNewswire/ -- In a congressional,hearing Sec...iscussed the,safety and importance of the research...ffairs (VA) as well as an absolute commitment to i...ingle veteran would feel improperly,treated or mis...
(Date:7/9/2008)... SAN DIEGO, July 9 /- A...announced positive results from a multiple-ascendi...ate the compound,s safety,pharmacokinetics and ph...vered oral drug candidate intended for the treatme...ions., The Phase 1b trial was a randomized, doubl...
(Date:7/8/2008)... MAIDENHEAD, England, July 8 /PRNewswire-First...dren Against the Leading,Vaccine-Preventable Cause...ountries of Cyprus, Hungary, the Kingdom of,Bahrai... for announcing,their decisions to routinely immun...l disease by adding PREVENAR(TM) PCV7 (Pneumococca...
(Date:7/8/2008)... GLP-1 Has Potential to Treat Type 2 Diabetes Us... Technology, CEDAR KNOLLS, N.J., July 8 /PRN... (Nasdaq: EMIS ) today announced findings from a ...1 peptide safely and effectively.,The study used a...ligen(R),technology, and was conducted at Universi...
Breaking Medicine Technology:Secretary Reinforces VA's Commitment to Research Safety and Veteran Focus 2Secretary Reinforces VA's Commitment to Research Safety and Veteran Focus 3Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 2Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 3Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 4Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 5Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules 2Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules 3Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations 2Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations 3BioSpace and the Massachusetts Biotechnology Council Launch 2008 Genetown 28TM 29 Hotbed Campaign 2545 1BioSpace and the Massachusetts Biotechnology Council Launch 2008 Genetown 28TM 29 Hotbed Campaign 2545 2Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non Small Cell Lung Cancer 2541 1Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non Small Cell Lung Cancer 2541 2Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non Small Cell Lung Cancer 2541 3Biofuels Sustainability 1842 1Biofuels Sustainability 1842 2Biofuels Sustainability 1842 3Protein in human hair shows promise for regenerating nerves 9372 1Protein in human hair shows promise for regenerating nerves 9372 2Protein in human hair shows promise for regenerating nerves 9372 3
... Switzerland, April 3, 2007 (PRIME NEWSWIRE) -- Ne...ogical and,pharmacokinetic profiles of Basilea,s (...ole and isavuconazole. Studies reported,both for c...phalosporin in late-stage development, and for isa...asive fungal infections,yielded further data on t...
...France, April 04, 2007 /PRNewswire/ -- Novagali Ph...y specialized in,ophthalmology, announces today po...f Vekacia(R) in children suffering from Vernal,Ker...t was shown,that both symptoms and signs of diseas...ermore, the tolerability to Vekacia(R),was excelle...
Other Medicine Technology:Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 2Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 4Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 5Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 6Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 7Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2
Rapid reagent impregnated disk test for presumptive identification of Candida albicans.
...sive Electronic Medical Records for small and larg...tient flow from check-in to check-out. Review the ...rent medications, to allergies, labs and charts al...ecords immediately. Communicate electronically wit...
Written specifically for urologists by a urologist, this EMR software utilizes touch screen technology to streamline your workflow and virtually eliminate the use of a cumbersome mouse. Its intuitive
...t Record is a new generation of advanced Electroni...the largest, numerically codified medical vocabula... data elements embedded in MedcomSoft Record, heal... an easy and intuitive point and click system and ...
Medicine Products: